戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 2+) signalling instability and Ca(2+) -based arrhythmogenicity.
2 risks of tumorigenicity, immunogenicity, and arrhythmogenicity.
3 ling, an effect that may contribute to their arrhythmogenicity.
4 l dispersion of repolarization and potential arrhythmogenicity.
5 sition and investigate mechanisms underlying arrhythmogenicity.
6 monstrated marked pacing-induced ventricular arrhythmogenicity.
7 t cardiac arrhythmias with relatively little arrhythmogenicity.
8 tion withdrawals due to cardiac ischemia and arrhythmogenicity.
9 y for preclinical evaluation of drug-induced arrhythmogenicity.
10 cross talk between EAT and the heart and its arrhythmogenicity.
11 nosis of cardiological patients and for drug arrhythmogenicity.
12 c substrate that could be a future source of arrhythmogenicity.
13  aberrant electrical conduction and enhanced arrhythmogenicity.
14 nary tool to assess preclinical drug-induced arrhythmogenicity.
15 t to the changes attributed to Ca(2+) -based arrhythmogenicity.
16 o evidence of adverse electrical remodeling, arrhythmogenicity, activation of a cellular immune respo
17 be an important factor underlying late-phase arrhythmogenicity after SMB transplantation.
18 f AF and may limit the role of Ca(2+) -based arrhythmogenicity after the onset of AF.
19 erstanding of cellular mechanisms underlying arrhythmogenicity and diastolic dysfunction.
20 and (3) the mechanism of alphaCT1 effects on arrhythmogenicity and GJ remodeling.
21 V remodeling, prevention of sudden death and arrhythmogenicity and structural stability of the athero
22 (iPSC-CMs) exhibited impaired contractility, arrhythmogenicity, and proinflammatory gene expression p
23 C effects on human cardiac contractility and arrhythmogenicity, and provides novel insight into the r
24  (2) investigate mechanisms underlying Pcell arrhythmogenicity; and compare Pcell and Vcell electroph
25                      ET-1 exhibited a higher arrhythmogenicity (arrhythmogenic index; ratio of number
26 ered DeltaAPD90 values accompanied the lower arrhythmogenicity associated with quinidine treatment.
27 ncluding endothelin-1 (ET-1), exhibit potent arrhythmogenicity, but the underlying cellular mechanism
28 C effects on human cardiac contractility and arrhythmogenicity by integrating experimental and comput
29                                  Ventricular arrhythmogenicity during isoproterenol testing is highly
30 The WT hiPSC-CMs did not exhibit any sign of arrhythmogenicity even at stimulation frequencies of 120
31 could recapitulate structural remodeling and arrhythmogenicity expected in chronic CAVB.
32  introduction of 100 nM isoprenaline induced arrhythmogenicity in both KCNE1-/- (n = 7) and wild-type
33 he gap junction protein connexin43 decreased arrhythmogenicity in cocultures, suggesting a specific m
34 ction potential prolongation and ventricular arrhythmogenicity in long QT syndrome 5.
35 e the technique's utility by evaluating drug arrhythmogenicity in murine cardiomyocytes that are tran
36                                          The arrhythmogenicity index was increased (P<0.001) and the
37             However, residual pulmonary vein arrhythmogenicity is a common mechanism of recurrence.
38 e whether elimination of pulmonary vein (PV) arrhythmogenicity is necessary for the efficacy of left
39 cardiac sodium channel mutation of which the arrhythmogenicity is revealed only at temperatures appro
40 cant Ca(2+)-transient irregularities, marked arrhythmogenicity manifested by early afterdepolarizatio
41 at RyR2 interactions are unlikely to explain arrhythmogenicity of LQTS-CaM mutations.
42 that lipomatous metaplasia may contribute to arrhythmogenicity of postinfarction scar.
43 To examine the electrophysiological basis of arrhythmogenicity of QT/T alternans in LQTS, the tridime
44                                          The arrhythmogenicity of QT/T alternans was primarily due to
45 obstructive hypertrophic cardiomyopathy, the arrhythmogenicity of the ablation scar appears to be ove
46 were reduced at the ICD, consistent with the arrhythmogenicity of the DKO hearts.
47 n important property that contributes to the arrhythmogenicity of the tissue substrate.
48 ling (PS) on human cardiac contractility and arrhythmogenicity remain unresolved.
49 onically failing heart, there was late-phase arrhythmogenicity specific to donor cell type.
50 , SHR hearts showed an increased ventricular arrhythmogenicity that stems primarily from tissue remod
51 ia-induced atrial WFPL shortening and atrial arrhythmogenicity to programmed electrical stimulation.
52 CaMKII-independent uptake exacerbates atrial arrhythmogenicity, while helping to maintain normal leve